Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrie E Ryan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Annals of Surgical Oncology|November 18, 2022
Oregovomab Plus Chemo in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5/GOG-3035)Stephanie N Gregory, A Leila Sarvestani, Carrie E Ryan, et al.
The American Surgeon|September 10, 2015
Long-term Outcomes Favor Duodenum-preserving Pancreatic Head Resection over Pylorus-preserving Pancreaticoduodenectomy for Chronic Pancreatitis: A Meta-analysis and Systematic ReviewPrashant B Sukharamwala, Krishen D Patel, Anthony F Teta, et al.
American Journal of Surgery|August 2, 2017
Regional differences for pancreaticoduodenectomy in Florida: Location mattersAlexander S Rosemurgy, Darrell J Downs, Forat Swaid, et al.
The American Surgeon|June 3, 2015
Reoperative Heller myotomy: more pain, less gainThomas W Wood, Sharona B Ross, Carrie E Ryan, et al.
Annals of Surgical Oncology|December 29, 2022
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)Stephanie N Gregory, Carrie E Ryan, Jonathan M Hernandez, et al.
The American Surgeon|May 25, 2016
High-Volume Hospitals with High-Volume and Low-Volume Surgeons: Is There a "Field Effect" for Pancreaticoduodenectomy?Thomas W Wood, Sharona B Ross, Ty A Bowman, et al.
Journal of Multidisciplinary Healthcare|December 15, 2015
Establishing a framework for building multidisciplinary programsCheryl Meguid, Carrie E Ryan, Barish H Edil, et al.
JAMA|June 14, 2024
Germline CDH1 Variants and Lifetime Cancer RiskCarrie E Ryan, Grace-Ann Fasaye, Amber F Gallanis, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocolJack H Victory, Emily C Smith, Carrie E Ryan, et al.
Cancer Discovery|July 30, 2025
Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growthSurajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Annals of Surgical Oncology|November 18, 2022
Oregovomab Plus Chemo in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5/GOG-3035)Stephanie N Gregory, A Leila Sarvestani, Carrie E Ryan, et al.
The American Surgeon|September 10, 2015
Long-term Outcomes Favor Duodenum-preserving Pancreatic Head Resection over Pylorus-preserving Pancreaticoduodenectomy for Chronic Pancreatitis: A Meta-analysis and Systematic ReviewPrashant B Sukharamwala, Krishen D Patel, Anthony F Teta, et al.
American Journal of Surgery|August 2, 2017
Regional differences for pancreaticoduodenectomy in Florida: Location mattersAlexander S Rosemurgy, Darrell J Downs, Forat Swaid, et al.
The American Surgeon|June 3, 2015
Reoperative Heller myotomy: more pain, less gainThomas W Wood, Sharona B Ross, Carrie E Ryan, et al.
Annals of Surgical Oncology|December 29, 2022
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)Stephanie N Gregory, Carrie E Ryan, Jonathan M Hernandez, et al.
The American Surgeon|May 25, 2016
High-Volume Hospitals with High-Volume and Low-Volume Surgeons: Is There a "Field Effect" for Pancreaticoduodenectomy?Thomas W Wood, Sharona B Ross, Ty A Bowman, et al.
Journal of Multidisciplinary Healthcare|December 15, 2015
Establishing a framework for building multidisciplinary programsCheryl Meguid, Carrie E Ryan, Barish H Edil, et al.
JAMA|June 14, 2024
Germline CDH1 Variants and Lifetime Cancer RiskCarrie E Ryan, Grace-Ann Fasaye, Amber F Gallanis, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocolJack H Victory, Emily C Smith, Carrie E Ryan, et al.
Cancer Discovery|July 30, 2025
Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growthSurajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, et al.
Pageof 3